Angioid Streaks Differential Diagnoses

1. Doyne RW. Choroidal and retinal changes. The result of blows on the eyes. Trans Ophthal. 1889. 9:128.

2. Knapp H. On the formation of dark angioid streaks as an unusual metamorphosis of retinal hemorrhage. Arch Ophthalmol. 1892. 21:289-292.

3. Klien BA. Angioid Streaks: A clinical and histopathologic study. American Journal of Ophthalmology. 1947. 30:955-68.

4. Abujamra S, Negretto AD, Saraceno JJ, Oliveira TL, Gomes AM. [Angioid streaks: fundoscopic analysis of 317 cases]. Arq Bras Oftalmol. 2008 Nov-Dec. 71(6):819-21. [QxMD MEDLINE Link].

5. Mansour AM, Ansari NH, Shields JA, Annesley WH Jr, Cronin CM, Stock EL. Evolution of angioid streaks. Ophthalmologica. 1993. 207(2):57-61. [QxMD MEDLINE Link].

6. Georgalas I, Papaconstantinou D, Koutsandrea C, Kalantzis G, Karagiannis D, Georgopoulos G, et al. Angioid streaks, clinical course, complications, and current therapeutic management. Ther Clin Risk Manag. 2009 Feb. 5 (1):81-9. [QxMD MEDLINE Link].

7. Mansour AM, Shields JA, Annesley WH Jr, el-Baba F, Tasman W, Tomer TL. Macular degeneration in angioid streaks. Ophthalmologica. 1988. 197 (1):36-41. [QxMD MEDLINE Link].

8. Spaide RF. Peau d'orange and angioid streaks: manifestations of Bruch membrane pathology. Retina. 2015 Mar. 35 (3):392-7. [QxMD MEDLINE Link].

9. Dhermy P. Histologie Angioid Streaks. Cosca G, Soubane G, eds. Neovasseaux Sous-Retiniens et Laser. Paris, France: 1987. 210-1.

10. M Abusamak and H Alrawashdeh. A Case of Papillophlebitis Caused by the Contraceptive Implant in a Healthy Young Woman with Angioid Streaks. Open Journal of Ophthalmology. 05/17/2021. 15:79-82. [Full Text].

11. Gass J, Donald M. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 4th ed. CV Mosby: 1997. Vol. 1: 120.

12. Piro PA, Scheraga D, Fine S. Angioid Streaks: Natural history and visual prognosis. Management of Retinal Vascular and Macular Disorders. Williams and Wilkins; 1983. 136-9.

13. Shoumnalieva-Ivanova V, Tanev I, Zdravkov Y, Monov S, Shumnalieva R. Angioid streaks in aagenaes syndrome. Int Ophthalmol. 2016 Sep 10. [QxMD MEDLINE Link].

14. Ungureanu E, Geamanu A, Careba I, Grecescu M, Gradinaru S. Angioid streaks - a rare cause of neovascular glaucoma. Case report. J Med Life. 2014. 7 Spec No. 4:71-3. [QxMD MEDLINE Link].

15. Chalam KV, Sambhav K. Optical Coherence Tomography Angiography in Retinal Diseases. J Ophthalmic Vis Res. 2016 Jan-Mar. 11 (1):84-92. [QxMD MEDLINE Link].

16. Gal-Or O, Balaratnasingam C, Freund KB. Optical coherence tomography angiography findings of choroidal neovascularization in pseudoxanthoma elasticum. Int J Retina Vitreous. 2015 Aug 7. 1:11. [QxMD MEDLINE Link].

17. Kubota M, Hayashi T, Arai K, Tsuneoka H. Choroidal neovascularization after blunt ocular trauma in angioid streaks. Clin Ophthalmol. 2013. 7:1347-51. [QxMD MEDLINE Link]. [Full Text].

18. Clarkson JG, Altman RD. Angioid streaks. Surv Ophthalmol. 1982 Mar-Apr. 26(5):235-46. [QxMD MEDLINE Link].

19. Ozdek S, Bozan E, Gürelik G, Hasanreisoglu B. Transpupillary thermotherapy for the treatment of choroidal neovascularization secondary to angioid streaks. Can J Ophthalmol. 2007 Feb. 42 (1):95-100. [QxMD MEDLINE Link].

20. Karacorlu M, Karacorlu S, Ozdemir H, et al. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol. 2002 Sep. 134(3):360-6. [QxMD MEDLINE Link].

21. Esen E, Sizmaz S, Demircan N. Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks. Indian J Ophthalmol. 2015 Jul. 63 (7):616-8. [QxMD MEDLINE Link].

22. Vaz-Pereira S, Collaço L, De Salvo G, van Zeller P. Intravitreal aflibercept for choroidal neovascularisation in angioid streaks. Eye (Lond). 2015 Sep. 29 (9):1236-8. [QxMD MEDLINE Link].

23. Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Am J Ophthalmol. 2009 Oct. 148(4):584-590.e2. [QxMD MEDLINE Link].

24. Neri P, Salvolini S, Mariotti C, Mercanti L, Celani S, Giovannini A. Long-term control of choroidal neovascularisation secondary to angioid streaks treated with intravitreal bevacizumab (Avastin). Br J Ophthalmol. 2009 Feb. 93(2):155-8. [QxMD MEDLINE Link].

25. Finger RP, Charbel Issa P, Hendig D, Scholl HP, Holz FG. Monthly Ranibizumab for Choroidal Neovascularizations Secondary to Angioid Streaks in Pseudoxanthoma Elasticum: A One-Year Prospective Study. Am J Ophthalmol. 2011 Jun 24. [QxMD MEDLINE Link].

26. Gliem M, Finger RP, Fimmers R, Brinkmann CK, Holz FG, Charbel Issa P. Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review. Retina. 2013 Jul-Aug. 33(7):1300-14. [QxMD MEDLINE Link].

27. Teixeira A, Mattos T, Velletri R, Teixeira R, Freire J, Moares N, et al. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2010 Sep-Oct. 41 (5):546-9. [QxMD MEDLINE Link].

28. Martinez-Serrano MG, Rodriguez-Reyes A, Guerrero-Naranjo JL, Salcedo-Villanueva G, Fromow-Guerra J, García-Aguirre G, et al. Long-term follow-up of patients with choroidal neovascularization due to angioid streaks. Clin Ophthalmol. 2016 Dec 19. 11:23-30. [QxMD MEDLINE Link].

29. Tilleul J, Mimoun G, Querques G, Puche N, Zerbib J, Lalloum F, et al. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up. Retina. 2016 Mar. 36 (3):483-91. [QxMD MEDLINE Link].

30. Yolcu U, Gundogan FC, Diner O. Drastic effect of ranibizumab on choroidal neovascularization in idiopathic angioid streaks. Arq Bras Oftalmol. 2015 Jul-Aug. 78 (4):257-9. [QxMD MEDLINE Link].

31. Ebran JM, Mimoun G, Cohen SY, Grenet T, Donati A, Jean-Pastor MJ, et al. [Treatment with ranibizumab for choroidal neovascularization secondary to a pseudoxanthoma elasticum: Results of the French observational study PiXEL]. J Fr Ophtalmol. 2016 Apr. 39 (4):370-5. [QxMD MEDLINE Link].

32. Finger RP, Charbel Issa P, Schmitz-Valckenberg S, Holz FG, Scholl HN. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina. 2011 Jul-Aug. 31 (7):1268-78. [QxMD MEDLINE Link].

33. Makri OE, Tsapardoni FN, Plotas P, Pallikari A, Georgakopoulos CD. Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab. Int Med Case Rep J. 2018. 11:229-231. [QxMD MEDLINE Link]. [Full Text].

34. Prabhu VV, Morris RJ, Shah PK, Narendran V. Combination treatment of low fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane secondary to angioid streaks in Paget's disease - 12 month results. Indian J Ophthalmol. 2011 Jul-Aug. 59(4):306-8. [QxMD MEDLINE Link]. [Full Text].

35. Artunay O, Yuzbasioglu E, Rasier R, Sengul A, Senel A, Bahcecioglu H. Combination treatment with intravitreal injection of ranibizumab and reduced-fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: Preliminary Clinical Results of 12-Month Follow-Up. Retina. 2011 Jul-Aug. 31(7):1279-86. [QxMD MEDLINE Link].

36. Eckstein M, Wells JA, Aylward B, Gregor Z, et al. Surgical removal of non-age-related subfoveal choroidal neovascular membranes. Eye. 1998. 12 (Pt 5):775-80. [QxMD MEDLINE Link].

37. Parolini B, Alkabes M, Baldi A, Pinackatt S. VISUAL RECOVERY AFTER AUTOLOGOUS RETINAL PIGMENT EPITHELIUM AND CHOROIDAL PATCH IN A PATIENT WITH CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS: LONG-TERM RESULTS. Retin Cases Brief Rep. 2016 Fall. 10 (4):368-72. [QxMD MEDLINE Link].

Mohammad Abusamak, MD, FICO, FRCS(Glasg), MRCS(Edin) Assistant Professor, Division of Ophthalmology, Al-Balqa Applied University, School of Medicine; Ophthalmologist, Amman Eye Clinic, Jordan

Mohammad Abusamak, MD, FICO, FRCS(Glasg), MRCS(Edin) is a member of the following medical societies: American Academy of Ophthalmology, American Society of Retina Specialists, International Council of Ophthalmology, Jordan Medical Association, Royal College of Physicians and Surgeons of Glasgow, Royal College of Surgeons of Edinburgh

Disclosure: Nothing to disclose.

Shauna Berry, DO Pediatric Ophthalmology and Neuro-ophthalmology

Shauna Berry, DO is a member of the following medical societies: American Academy of Ophthalmology, American Osteopathic Association, American Osteopathic Colleges of Ophthalmology and Otolaryngology-Head and Neck Surgery, Florida Osteopathic Medical Association, Women in Ophthalmology, Inc

Disclosure: Nothing to disclose.

Ama Sadaka, MD Resident Physician, Department of Ophthalmology, University of Cincinnati Hospital

Ama Sadaka, MD is a member of the following medical societies: Alpha Omega Alpha

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Steve Charles, MD Founder and CEO of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine

Disclosure: Received royalty and consulting fees for: Alcon Laboratories.

Andrew G Lee, MD Chair, Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital; Clinical Professor, Associate Program Director, Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch School of Medicine; Clinical Professor, Department of Surgery, Division of Head and Neck Surgery, University of Texas MD Anderson Cancer Center; Professor of Ophthalmology, Neurology, and Neurological Surgery, Weill Medical College of Cornell University; Clinical Associate Professor, University of Buffalo, State University of New York School of Medicine

Andrew G Lee, MD is a member of the following medical societies: American Academy of Ophthalmology, American Geriatrics Society, Houston Neurological Society, Houston Ophthalmological Society, International Council of Ophthalmology, North American Neuro-Ophthalmology Society, Texas Ophthalmological Association

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: AstraZeneca; Bristol Myers Squibb; Horizon<br/>Serve(d) as a speaker or a member of a speakers bureau for: Horizon<br/>Received ownership interest from Credential Protection for other.

Russell P Jayne, MD Vitreoretinal Surgeon, The Retina Center at Las Vegas

Russell P Jayne, MD is a member of the following medical societies: American Medical Association, American Society of Cataract and Refractive Surgery, American Society of Retina Specialists

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article